Have You Encountered Plasminogen Deficiency In Your Practice? An Overview On Management & New Therapeutic Options
Congenital Plasminogen Deficiency is a rare genetic disease that can have devastating effects on multiple organ systems throughout the body. Congenital Plasminogen Deficiency predominantly affects infants and children, with the most severe manifestations being reported in the pediatric population. Fibrinous lesions accumulate on mucosal membrane surfaces, posing significant risk and organ-compromising effects. This symposium will cover historical management approaches for PLGD as well as clinical trial information and real-world evidence involving a new, systemic plasminogen replacement therapy, currently under FDA review.
Shira L. Robbins, MD, FAAO, FAAP – Professor of Ophthalmology, UC San Diego; Education Director, Pediatric Ophthalmology & Strabismus, Shiley Eye Institute
Per Morten Sandset, MD – Professor, Vice Rector, University of Oslo; Senior Consultant, Oslo University Hospital Rikshospitalet